Amphastar Pharmaceuticals, Inc. — Director's Dealing 2015

Jun 18, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2015-03-27

Reporting Person: Purchase Marilyn J. (Former Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-03-27	Common Stock	F	1639	$15.43	Disposed	43263	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	16044	Indirect

Footnotes

F1: The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of deferred stock units, or DSUs.

F2: The shares are held directly by the Purchase Family Trust for which the reporting rerson serves as co-trustee.